{"id":2233,"date":"2018-12-13T15:45:47","date_gmt":"2018-12-13T12:45:47","guid":{"rendered":"https:\/\/www.powerterapi.com\/?page_id=2233"},"modified":"2018-12-13T15:45:47","modified_gmt":"2018-12-13T12:45:47","slug":"kanser-ve-apiterapi","status":"publish","type":"page","link":"https:\/\/www.powerterapi.com\/?page_id=2233","title":{"rendered":"KANSER VE AP\u0130TERAP\u0130"},"content":{"rendered":"

T\u00fcm kanser t\u00fcrlerinde, Kanser yay\u0131l\u0131m\u0131 ve t\u00fcm\u00f6r b\u00fcy\u00fcmesinin, ar\u0131 \u00fcr\u00fcnleri kullan\u0131m\u0131yla, yar\u0131 yar\u0131ya oranlarda yava\u015flamas\u0131, hastal\u0131\u011f\u0131n direncinin k\u0131r\u0131lmas\u0131, tedaviye \u00f6nemli zaman dilimleri kazan\u0131lmas\u0131 ve ya\u015fam s\u00fcresinin uzamas\u0131na ili\u015fkin ara\u015ft\u0131rmalar\u0131 a\u015fa\u011f\u0131da bulabilirsiniz.<\/p>\n

Ba\u011f\u0131\u015f\u0131kl\u0131k sistemini g\u00fc\u00e7lendiren y\u00f6nleriyle de kanser tedavisine art\u0131 destek sa\u011flan\u0131r. Hastan\u0131n dayanma g\u00fcc\u00fc, ya\u015fam kalitesi ve genel direncinde de y\u00fckselme g\u00f6r\u00fcl\u00fcr. Bu say\u0131lanlar hastan\u0131n, y\u00fcksek moral ve hastal\u0131kla m\u00fccadele azmine sahip olmas\u0131 i\u00e7in g\u00fc\u00e7l\u00fc bir zemin olu\u015fturabilir. \u0130nsan\u0131n psikolojik y\u00f6n\u00fcn\u00fcn a\u011f\u0131rl\u0131\u011f\u0131 dikkate al\u0131nd\u0131\u011f\u0131nda ar\u0131 \u00fcr\u00fcnleriyle art\u0131 olarak gelen bu katk\u0131lar\u0131n da \u00f6nemi tart\u0131\u015f\u0131lmaz.<\/p>\n

\u00d6te yandan kemoterapi ve radyoterapinin yan etkilerine kar\u015f\u0131 i\u00e7 organlar\u0131 koruyucu, hastan\u0131n h\u0131zl\u0131 toparlanmas\u0131n\u0131 sa\u011flay\u0131c\u0131 etkileriyle ilgili ara\u015ft\u0131rmalara da bu sayfada ula\u015fabilirsiniz.<\/p>\n

Ar\u0131 \u00fcr\u00fcnleri i\u00e7erdi\u011fi flavanoidler ile E vitaminine g\u00f6re 200 kat daha fazla antioksidan de\u011fere sahiptir. Kanser risklerini azaltan bu y\u00f6n\u00fcyle de dikkat \u00e7ekici olup, koruyucu t\u0131p anlam\u0131nda da kullan\u0131lmas\u0131 s\u00f6zkonusudur.<\/p>\n

\u00d6nemli Not:<\/p>\n

Ar\u0131 \u00fcr\u00fcnlerden beklenen yararlar herkes i\u00e7in ayn\u0131 \u015fekilde ortaya \u00e7\u0131kmayabilir. Ar\u0131 \u00fcr\u00fcnlerine genel allerjisi olanlar\u0131n \u00fcr\u00fcnleri kullanmadan \u00f6nce bir allerji uzman\u0131na dan\u0131\u015fmalar\u0131 \u00f6nerilir. Ar\u0131 \u00fcr\u00fcnleri genel olarak tedaviye destek kategorisinde olup ba\u015fl\u0131 ba\u015f\u0131na bir tedavi olarak de\u011ferlendirilemezler.<\/p>\n

Konuyla \u0130lgili Y\u00fczlerce \u00dcniversite Ara\u015ft\u0131rmalar\u0131ndan Baz\u0131lar\u0131:<\/strong><\/p>\n

Kanser Yay\u0131l\u0131m\u0131n\u0131(metastaz) Yar\u0131 Yar\u0131ya Yava\u015flat\u0131yor:<\/strong><\/p>\n

Oxford \u00dcniversitesi’nin bilimsel yay\u0131nlar\u0131ndan biri olan Oxfordjournals’da yer verilen Japon Gifu \u0130la\u00e7 Bilimlerinde yap\u0131lan ara\u015ft\u0131rmaya g\u00f6re ar\u0131 s\u00fct\u00fc anti-t\u00fcm\u00f6r etkiler g\u00f6steriyor. T\u00fcm\u00f6r b\u00fcy\u00fcmesini yava\u015flatan ve durduran bu etkilere ek olarak ar\u0131 s\u00fct\u00fcn\u00fcn etkin maddelerinden olan HDA-10 kanser h\u00fccrelerinin yayg\u0131nla\u015fmas\u0131n\u0131 ve yer de\u011fi\u015ftirmesini (metastaz) de k\u0131smen engelliyor. Detayl\u0131 bilgi i\u00e7in:<\/p>\n

http:\/\/www.ncbi.nlm.nih.gov\/sites\/entrez\/3570105?dopt=Abstract&holding=f100<\/p>\n

Kuyushu Universitesi’den Prof. Nakaya ve akademisyen ekibinin deneysel \u00e7al\u0131\u015fmalar\u0131, ar\u0131 s\u00fct\u00fcn\u00fcn anti-\u00e7evrel-estrojen aktiveleri ile g\u00f6\u011f\u00fcs kanser h\u00fccrelerinin yayg\u0131nla\u015fmas\u0131nda etkin olan bu \u00e7evrel etkilerin \u00f6n\u00fcne ge\u00e7ti\u011fi do\u011frulan\u0131yor. Detayl\u0131 bilgi i\u00e7in:<\/p>\n

http:\/\/www.jstage.jst.go.jp\/article\/bbb\/71\/1\/cancer\/_34<\/p>\n

Propolisin etkin maddelerinden olan caffeic Acid Penetil Ester(CAPE)’in t\u00fcm\u00f6r ve metastaz \u00fczerinde etkilerini ara\u015ft\u0131ran Prof. Hui-Fen Liao ve Tayvan Memorial Hastanesi Onkologlar\u0131n\u0131n sonu\u00e7 raporunda propolis i\u00e7eri\u011finin etkileriyle kanser h\u00fccrelerinin yay\u0131l\u0131m h\u0131z\u0131n\u0131n, kanser t\u00fcrlerine g\u00f6re y\u00fczde 47-52 aras\u0131nda oranlara kadar azald\u0131\u011f\u0131 belirtiliyor. Detayl\u0131 bilgi i\u00e7in:<\/p>\n

http:\/\/pubs.acs.org\/doi\/abs\/10.1021\/jf034729d<\/p>\n

T\u00fcm\u00f6r B\u00fcy\u00fcmesini bask\u0131l\u0131yor:<\/strong><\/p>\n

Prof. M. Demestre, Alman, Amerikal\u0131 ve \u0130talyan \u00fcniversitelerinden bilim adamlar\u0131yla beraber propolis ekstrakt\u0131n\u0131n uzun d\u00f6nemli etkilerini g\u00f6zlediler. Bu uzun s\u00fcreli deneyin sonucunda; propolisin 100 g\u00fcnl\u00fck kullan\u0131m s\u00fcrecinde t\u00fcm\u00f6r b\u00fcy\u00fcmesinin \u00f6nemli oranda bask\u0131land\u0131\u011f\u0131 bu oran\u0131n kanser t\u00fcrlerine g\u00f6re k\u00fc\u00e7\u00fck sapmalar g\u00f6sterdi\u011fi, ortalama de\u011ferin ise y\u00fczde 47,5 oldu\u011fu a\u00e7\u0131klan\u0131yor.<\/p>\n

Detayl\u0131 bilgi i\u00e7in: http:\/\/www3.interscience.wiley.com\/journal\/121373548\/abstract<\/p>\n

Brezilya’l\u0131 Prof. Michelle C.Bufalo \u00f6nc\u00fcl\u00fc\u011f\u00fcnde baz\u0131 bilim adamlar\u0131n\u0131n kat\u0131l\u0131m\u0131yla yap\u0131lan deneylerin sonu\u00e7lar\u0131n\u0131 dayanak yapan bilimsel makalede propolisin g\u00fc\u00e7l\u00fc anti-t\u00fcm\u00f6r etkileri vurgulan\u0131yor. Anti-iltihap, anti-mikrobiyal, anti-viral \u00f6zelliklerine de dikkat \u00e7ekiliyor. Detayl\u0131 bilgi i\u00e7in:<\/p>\n

http:\/\/ecam.oxfordjournals.org\/cgi\/content\/full\/nem147<\/p>\n

T\u00fcm\u00f6r Dayan\u0131kl\u0131l\u0131\u011f\u0131n\u0131 Azalt\u0131yor: <\/strong><\/p>\n

Molecular Nutrition and Food Research dergisinin Aral\u0131k say\u0131s\u0131nda yay\u0131nlanan ara\u015ft\u0131rmada Propolisin etkin maddelerinden CAPE ve quertin’in propolis kullan\u0131m\u0131yla ortaya \u00e7\u0131kan \u00e7ok ilgin\u00e7 bir etkisi ortaya \u00e7\u0131kar\u0131l\u0131yor. Buna g\u00f6re bu etkin maddeler t\u00fcm\u00f6rlerin kendi kan yollar\u0131n\u0131 in\u015fa etmesini engelleyerek, t\u00fcm\u00f6r geli\u015fmesinin ve dayan\u0131kl\u0131l\u0131\u011f\u0131n\u0131n \u00f6n\u00fcn\u00fc kesiyor. Detayl\u0131 bilgi i\u00e7in:<\/p>\n

http:\/\/www3.interscience.wiley.com\/journal\/121553347\/abstract?CRETRY=1&SRETRY=0<\/p>\n

H\u0131rvatistan’da 2009 Temmuz’unda bir akademisyen grup taraf\u0131ndan yap\u0131lan ara\u015ft\u0131rmada propolisin di\u011fer bir ilgin\u00e7 etkisi daha ortaya \u00e7\u0131kar\u0131l\u0131yor. Propolis Ekstrakt\u0131n\u0131n Radyoterapi s\u00fcre\u00e7lerinde sa\u011fl\u0131kl\u0131 doku ve h\u00fccreleri koruyucu etkisini ima eden bir dizi sonu\u00e7 al\u0131n\u0131yor. Detayl\u0131 bilgi i\u00e7in:<\/p>\n

http:\/\/versita.metapress.com\/content\/y726wn4010x6x388\/?p=2295604bd48642c3bba2e3b578930b62&pi=0<\/p>\n

Kanserli Ya\u015fam S\u00fcresi Belirgin \u015eekilde Uzuyor:<\/strong><\/p>\n

Japonya Fujisaki Enstit\u00fcs\u00fc Hayashibara Biyokimya Labaratuarlar\u0131’nda t\u00fcm\u00f6r ta\u015f\u0131yan fareler \u00fczerinde 2003 Eyl\u00fcl\u00fcnde yap\u0131lan ara\u015ft\u0131rmalarda ar\u0131 s\u00fct\u00fc kullan\u0131m\u0131yla farelerin ya\u015fam s\u00fcrelerinin uzad\u0131\u011f\u0131 ve DNA hasarlar\u0131n\u0131n azald\u0131\u011f\u0131 belirtiliyor. Yine bu ara\u015ft\u0131rmaya g\u00f6re, tedavi g\u00f6ren kanser hastalar\u0131n\u0131n kar\u015f\u0131la\u015ft\u0131\u011f\u0131 \u00f6nemli sorunlardan biri olan kemik ili\u011fi aktivasyonlar\u0131ndaki gerileme sonucu k\u0131rm\u0131z\u0131 ve beyaz kan h\u00fccrelerinin azalmas\u0131ndan ar\u0131 s\u00fct\u00fcyle korunmak m\u00fcmk\u00fcn. Detayl\u0131 bilgi i\u00e7in:<\/p>\n

http:\/\/www.sciencedirect.com\/science?_ob=ArticleURL&_udi=B6T6J-49321TD<–t\u0131klay\u0131n\u0131z..<\/p>\n

\u0130nternational Immunopharmacology dergisinin 2005 Nisan say\u0131s\u0131nda; 679-688 sayfalar\u0131 aras\u0131nda yay\u0131nlanan \u00e7al\u0131\u015fma t\u00fcm\u00f6r b\u00fcy\u00fcmesi ve olu\u015fumuna kar\u015f\u0131 ar\u0131 s\u00fct\u00fcn\u00fcn etkilerini konu al\u0131yor. ve Prof. Bincoletto ile bir akademisyen grubunun ger\u00e7ekle\u015ftirdi\u011fi ara\u015ft\u0131rmada oksidatif DNA bozulmas\u0131 uygulanan farelere 16 hafta boyunca ar\u0131 s\u00fct\u00fc verildi\u011fi bunun sonucunda DNA bozulmalar\u0131n\u0131n azalmas\u0131yla ya\u015fam s\u00fcrelerinin belirgin \u015fekilde uzad\u0131\u011f\u0131 belirtiliyor. Detayl\u0131 bilgi i\u00e7in:<\/p>\n

www.ncbi.nlm.nih.gov\/pubmed\/15710337<\/p>\n

Akci\u011fer T\u00fcm\u00f6rlerinin Say\u0131s\u0131 Propolis Kullan\u0131lanlarda Kullan\u0131lmayanlara<\/strong><\/p>\n

G\u00f6re 4 Kat Daha Az<\/strong><\/p>\n

Oyama Universitesi Farmakoloji B\u00f6l\u00fcm\u00fcnden 10 Japon Bilim Adam\u0131’n\u0131n Science Direct’de yay\u0131nlanan ara\u015ft\u0131rmas\u0131na g\u00f6re, Akci\u011fer Kanseri’nin ilerlemesine kar\u015f\u0131 propolis kullan\u0131m\u0131 engelleme etkisi g\u00f6steriyor.<\/p>\n

Deneyde t\u00fct\u00fcn bazl\u0131 kanserojenlere 7 hafta yo\u011fun \u015fekilde maruz b\u0131rak\u0131lmas\u0131yla fare akci\u011ferlerinde t\u00fcm\u00f6r olu\u015fumlar\u0131 sa\u011flan\u0131yor. Daha sonra 16 hafta boyunca g\u00fcnl\u00fck 100mg\/kg oran\u0131nda propolis a\u011f\u0131z yoluyla veriliyor. Sadece kanserojene maruz b\u0131rak\u0131l\u0131p propolis verilmeyen farelerdeki t\u00fcm\u00f6r say\u0131s\u0131(ortalama 12,3), kanserojen sonras\u0131 propolis uygulanan farelerdeki t\u00fcm\u00f6r say\u0131s\u0131na(ortalama 3,5) g\u00f6re 4 kat civar\u0131nda fazla oluyor. Sonu\u00e7 b\u00f6l\u00fcm\u00fcnde, “Bulgulara g\u00f6re propolis kemoprevensif i\u00e7erik olarak akci\u011fer kanseri vakalar\u0131nda insanlarda kullan\u0131labilir” deniyor.<\/p>\n

Ara\u015ft\u0131ramn\u0131n tam metni i\u00e7in a\u015fa\u011f\u0131daki linki t\u0131klay\u0131n\u0131z:<\/p>\n

http:\/\/www.mundialsiglo21.com\/novedades\/Inhibitory.pdf<\/p>\n

Akci\u011fer Kanseri’nde Uygulanan Tedavinin T\u00fcm\u00f6r B\u00fcy\u00fcmesi \u00dczerindeki Anl\u0131k Ba\u015far\u0131s\u0131 Propolis Kullan\u0131m\u0131 ile Y\u00fczde 30 Oran\u0131nda Art\u0131yor:<\/strong><\/p>\n

Radyasyon Onkolojisi B\u00f6l\u00fcm\u00fcn’den Tayvan’l\u0131 5 Bilim Adam\u0131’n\u0131n yapt\u0131\u011f\u0131 Journal of Radiation Research dergisinin(Japonya) 45. say\u0131s\u0131nda 253-260 sayfalar\u0131nda yay\u0131nlanan ara\u015ft\u0131rmaya g\u00f6re, sadece tedavi ile t\u00fcm\u00f6r b\u00fcy\u00fcmesi 48 saat sonra \u00f6l\u00e7\u00fcld\u00fc\u011f\u00fcnde y\u00fczde 46 oran\u0131nda durdurulabilmesine kar\u015f\u0131n, propolis ile bu miktar ayn\u0131 zaman diliminde y\u00fczde 60’lara \u00e7\u0131k\u0131yor. 72 saat sonra ise bu oran y\u00fczde 67’ye y\u00fckseliyor. Sa\u011fl\u0131kl\u0131 h\u00fccrelerde radyasyona ba\u011fl\u0131 hasar oran\u0131 ise t\u00fcm\u00f6r h\u00fccrelerinin aksine d\u00fc\u015f\u00fcyor.<\/p>\n

Ara\u015ft\u0131rman\u0131n sonu\u00e7 b\u00f6l\u00fcm\u00fcnde propolis i\u00e7eriklerinin antioksidan etkilerine dikkat \u00e7ekilerek \u00f6zetle \u015f\u00f6yle deniyor:<\/strong><\/p>\n

“Akci\u011fer Kanser h\u00fccreleri \u00fczerinde \u00f6ld\u00fcr\u00fcc\u00fc \u0131\u015f\u0131n etkisine benzer etki g\u00f6steriyor. Bu a\u00e7\u0131dan radyoterapiye destekleyici olarak beraber kullan\u0131labilir. Propolis, ayr\u0131ca, hastal\u0131\u011f\u0131n tekrar etme durumuna kar\u015f\u0131 da yard\u0131mc\u0131 olabilir.”<\/p>\n

Ara\u015ft\u0131rmaya ula\u015fmak i\u00e7in a\u015fa\u011f\u0131daki linki t\u0131klay\u0131n\u0131z:<\/p>\n

http:\/\/www.jstage.jst.go.jp\/article\/jrr\/45\/2\/45_253\/_article<\/p>\n

Kemoterapi’nin Karaci\u011fer ve B\u00f6breklerde Yol A\u00e7t\u0131\u011f\u0131 Oksidatif Bask\u0131 ve Doku Hasar\u0131 ve H\u00fccre \u00d6l\u00fcm\u00fc Ar\u0131 S\u00fct\u00fc Kullan\u0131m\u0131 ile Belirgin \u015eekilde Azal\u0131yor:<\/strong><\/p>\n

Erzurum Atat\u00fcrk \u00dcniversitesi’nde May\u0131s 2011 tarihinde 9 Bilim Adam\u0131 taraf\u0131ndan ger\u00e7ekle\u015ftirilen bir ara\u015ft\u0131rmaya Oksidatif \u0130la\u00e7lar ve H\u00fccre Dayan\u0131kl\u0131l\u0131\u011f\u0131 ba\u015fl\u0131\u011f\u0131 alt\u0131nda uluslararas\u0131 yay\u0131nlarda yer verildi. Ali Karadeniz, Nejdet Simsek, Emre Karakus, Serap Yild\u0131r\u0131m, Adem Kara, \u0130smail Can, Fikrullah Kisa, Habib Emre ve Mehmet Turkeli taraf\u0131ndan ger\u00e7ekle\u015ftirilen ara\u015ft\u0131rmada kanser tedavisinde yo\u011fun olarak kullan\u0131lan \u00f6nemli kemoterapi i\u00e7eri\u011fi Cisplatin’in karaci\u011fer ve b\u00f6breklerdeki y\u0131k\u0131m\u0131na kar\u015f\u0131 ar\u0131 s\u00fct\u00fc kullan\u0131m\u0131 \u00f6neriliyor.<\/p>\n

Sonu\u00e7 k\u0131sm\u0131nda \u015f\u00f6yle deniyor:<\/p>\n

“Sonu\u00e7 olarak Cisplatin(CDDP) tedavisi karaci\u011fer ve b\u00f6breklerde doza ba\u011fl\u0131 olarak de\u011fi\u015fik seviyelerde ortaya \u00e7\u0131kar\u0131rken, deneklerde ar\u0131 s\u00fct\u00fc kullan\u0131m\u0131 bu zarar\u0131 azaltm\u0131\u015ft\u0131r. Bu koruma ar\u0131 s\u00fct\u00fcn\u00fcn sa\u011fl\u0131kl\u0131 h\u00fccrelerin \u00f6l\u00fcm\u00fcn\u00fc azalt\u0131c\u0131 etkisinden, antioksidan olmas\u0131 ya da serbest radikalleri temizleyen etkilerinden kaynaklanm\u0131\u015f olabilir. Netice olarak, ar\u0131 s\u00fct\u00fc kullan\u0131m\u0131 kemoterapinin karaci\u011fer ve b\u00f6brekler \u00fczerindeki toksit etkilerinden korunmada rol oynayabilir.”<\/p>\n

Ara\u015ft\u0131rmay\u0131 kaleme al\u0131nd\u0131\u011f\u0131 orjinal \u0130ngilizce’de okumak i\u00e7in buray\u0131 t\u0131klay\u0131n\u0131z..<\/p>\n

Not: Yukar\u0131daki ara\u015ft\u0131rmalarda hastal\u0131kl\u0131 h\u00fccreleri ise bloke edici \u00f6zelli\u011fi ile bu ara\u015ft\u0131rmada ortaya \u00e7\u0131kan sa\u011fl\u0131kl\u0131 h\u00fccreleri koruyucu etkisi ar\u0131 s\u00fct\u00fcn\u00fcn harikulade se\u00e7ici etkilerini ve getirdi\u011fi avantajlar\u0131n b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc net bir \u015fekilde g\u00f6steriyor.<\/p>\n

Beyin T\u00fcm\u00f6r\u00fc Tedavisi’nin Uygulanabilirli\u011fi ve Ba\u015far\u0131 \u015eans\u0131 Ar\u0131 S\u00fct\u00fc ile Art\u0131yor:<\/strong><\/p>\n

Journal of Neurological Sciences dergisinin 28’inci say\u0131s\u0131nda 475-486 sayfalar\u0131nda yay\u0131nlanan Nisan 2011 tarihli bir ara\u015ft\u0131rma Kayseri E\u011fitim ve Ara\u015ft\u0131rma Hastanesi Radyasyon Onkoloji B\u00f6l\u00fcm\u00fc’nden Uzman Doktorlar Yasemin Benderli Cihan, Erkan G\u00f6cen ve Patoloji B\u00f6l\u00fcm\u00fc’nden Vedat Arsav taraf\u0131ndan ger\u00e7ekle\u015ftirilmi\u015f.<\/p>\n

Ara\u015ft\u0131rmaya g\u00f6re, radyoterapi s\u00fcrecinde ar\u0131 s\u00fct\u00fc kullan\u0131m\u0131 radyasyona ba\u011fl\u0131 beyin dokusu hasarlar\u0131n\u0131 azalt\u0131yor. T\u00fcm\u00f6r kontrol\u00fc i\u00e7in uygulanan doz miktar\u0131n\u0131n bu hasar ile s\u0131n\u0131rland\u0131\u011f\u0131na dikkat \u00e7ekilen ara\u015ft\u0131rma sonucuna g\u00f6re t\u00fcm\u00f6r kontrol\u00fc ar\u0131 s\u00fct\u00fc kullan\u0131m\u0131yla art\u0131r\u0131labilir.<\/p>\n

Yay\u0131ndan baz\u0131 b\u00f6l\u00fcmler \u015f\u00f6yle:<\/p>\n

“Radyoterapi, primer santral sinir sistemi t\u00fcm\u00f6rleri ve metastazlar\u0131nda uygulanan tedavi modalitelerinden biridir. Radyoterapinin amac\u0131, beyinde normal dokuyu olabildi\u011fince korumak suretiyle, t\u00fcm\u00f6r dokusuna maksimum doz vermektir. Radyoterapide doz art\u0131r\u0131l\u0131rken, lokal t\u00fcm\u00f6r kontrol\u00fcnde de buna paralel bir art\u0131\u015f elde etmek m\u00fcmk\u00fcnd\u00fcr. Ancak, normal dokudaki komplikasyon riski de beraberinde artar. Dolay\u0131s\u0131yla, t\u00fcm\u00f6r kontrol\u00fc, bir anlamda beyinde normal dokunun radyoterapiye tolerans\u0131na ba\u011fl\u0131d\u0131r.”<\/p>\n

“Ar\u0131 s\u00fct\u00fcn\u00fcn antioksidatif etkisi, yap\u0131s\u0131nda bulundurdu\u011fu fenolik bile\u015fikleri veya polifenollerle sa\u011flanmaktad\u0131r. Ayr\u0131ca bu bile\u015fiklerin, antiinflamatuvar, antikarsinojenik, termojenik, probiyotik ve antimikrobiyal \u00f6zelliklere de sahip oldu\u011fu insan, hayvan ve in vitro \u00e7al\u0131\u015fmalarla kan\u0131tlanm\u0131\u015ft\u0131r. Ar\u0131 s\u00fct\u00fcn\u00fcn deney hayvanlar\u0131nda \u00e7ok say\u0131da farmakolojik aktivitesi tespit edilmi\u015ftir; antit\u00fcm\u00f6ral, antimikrobiyal, alerjik reaksiyonlar\u0131n bask\u0131lanmas\u0131, kan kolesterol\u00fcn\u00fc d\u00fc\u015f\u00fcr\u00fcc\u00fc etkisi, kanser ve HIV hastalar\u0131nda h\u00fccre hasar\u0131n\u0131n \u00f6nlenmesi, yara iyile\u015ftirici ve geli\u015fmeyi h\u0131zland\u0131r\u0131c\u0131 etki, vazodilatatif, anti-inflammatuvar aktivite gibi bir\u00e7ok etkiye sahiptir.”<\/p>\n

“Ar\u0131 s\u00fct\u00fcn\u00fcn deneysel \u00e7al\u0131\u015fmalarda antineoplastik ve toksik ila\u00e7lar\u0131n neden oldu\u011fu organ hasar\u0131na kar\u015f\u0131 antioksidan etki ile koruyucu oldu\u011fu g\u00f6sterilmesine ra\u011fmen iyonla\u015ft\u0131r\u0131c\u0131 radyasyona ba\u011fl\u0131 beyin hasar\u0131nda \u00f6nleyici rol\u00fc olup olmad\u0131\u011f\u0131 ile ilgili literat\u00fcre rastlan\u0131lmad\u0131. Ar\u0131 s\u00fct\u00fcn\u00fcn \u0131\u015f\u0131n tedavisi g\u00f6ren hastalarda iyonize radyasyona ba\u011fl\u0131 toksisiteyi \u00f6nleyici etkisinin belirlenmesi; bundan sonra yap\u0131lacak \u00e7al\u0131\u015fmalara \u0131\u015f\u0131k tutmakla birlikte alternatif do\u011fal bir antioksidan g\u0131da maddesinin destekleyici tedavide yerini almas\u0131 a\u00e7\u0131s\u0131ndan da \u00f6nemlidir.”<\/p>\n

Ara\u015ft\u0131rman\u0131n sonu\u00e7 b\u00f6l\u00fcm\u00fcnde ar\u0131 s\u00fct\u00fc kullan\u0131m\u0131 \u00f6nerilerek, \u015f\u00f6yle deniyor: “Bu ara\u015ft\u0131rma sonucuna g\u00f6re elde edilen bulgular \u0131\u015f\u0131\u011f\u0131nda do\u011fal, yan etkisi olmayan ar\u0131 s\u00fct\u00fcn\u00fcn beyine radyoterapi uygulanan hastalarda \u0131\u015f\u0131n tedavisinin sebep oldu\u011fu olumsuz etkileri \u00f6nlemek i\u00e7in tedavi \u00f6ncesinde ve sonras\u0131nda ar\u0131 s\u00fct\u00fc verilmesi tavsiye edilebilir. Ara\u015ft\u0131rmam\u0131zda tespit etti\u011fimiz olumlu etkiler, ar\u0131 s\u00fct\u00fcn\u00fcn ba\u015fta antioksidatif etki olmak \u00fczere faydal\u0131 biyolojik aktivitelerine atfedilebilir. Konuyla ilgili klinik \u00e7al\u0131\u015fmalar\u0131n tasarlanmas\u0131 ve uygulanmas\u0131 daha etkin stratejilerin olu\u015fturulmas\u0131n\u0131 sa\u011flayacakt\u0131r.”<\/p>\n

Ara\u015ft\u0131rman\u0131n detayl\u0131 anlat\u0131m\u0131n\u0131 i\u00e7eren yay\u0131n\u0131n tam metni i\u00e7in buraya t\u0131klay\u0131n\u0131z:<\/p>\n

www.jns.dergisi.org\/text.php3?id=467<\/p>\n

Kansere kar\u015f\u0131 ve ba\u015fka konularda ar\u0131 \u00fcr\u00fcnlerini kullananlar\u0131n baz\u0131 tan\u0131kl\u0131klar\u0131 i\u00e7in buraya t\u0131klay\u0131n\u0131z..<—-<\/p>\n

–>Ba\u011f\u0131\u015f\u0131kl\u0131k sistemiyle ilgili etkileri konusunda detayl\u0131 bilgi i\u00e7in t\u0131klay\u0131n\u0131z<–<\/p>\n

Ar\u0131 S\u00fct\u00fc, Polen, Propolis, Ger\u00e7ek Bal Gibi Ar\u0131 \u00dcr\u00fcnlerinin Di\u011fer Say\u0131s\u0131z Yararlar\u0131na Anasayfa’m\u0131zdan Ula\u015fabilirsiniz. <–T\u0131klay\u0131n\u0131z.<\/p>\n

—>Pe\u015fin ve taksitli fiyatlar\u0131m\u0131z\u0131 ve kredi kart\u0131na taksit se\u00e7eneklerimizi g\u00f6rmek i\u00e7in buraya t\u0131klay\u0131n\u0131z…<—<\/p>\n

Ar\u0131 s\u00fct\u00fcyle ilgili baz\u0131 ara\u015ft\u0131rmalar\/referanslar: <\/strong><\/p>\n

Risau W. Mechanisms of angiogenesis. Nature ( 1997;) 386:: 671\u20134. [CrossRef][Medline]<\/p>\n

Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature ( 2000;) 407:: 242\u20138. [CrossRef][Medline]<\/p>\n

Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, et al. Role of PIGF in the intra- and inter-molecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med ( 2003;) 9:: 936\u201343. [CrossRef][Web of Science][Medline]<\/p>\n

Folkman J, Klagsbrun M. Angiogenic factors. Science ( 1987;) 235:: 442\u20137. [Abstract\/Free Full Text]<\/p>\n

Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med ( 1999;) 5:: 1359\u201364. [CrossRef][Web of Science][Medline]<\/p>\n

Kerbel RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis ( 2000;) 21:: 505\u201315. [Abstract\/Free Full Text]<\/p>\n

Ferrara N. Vascular endothelial growth factor. Basic science and clinical progress. Endocr Rev ( 2004;) 25:: 581\u2013611. [Abstract\/Free Full Text]<\/p>\n

Zachary I. VEGF signaling: integration and multi-tasking in endothelial cell biology. Biochem Soc Trans ( 2003;) 31:: 1171\u20137. [Web of Science][Medline]<\/p>\n

Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med ( 1995;) 1:: 27\u201331. [CrossRef][Web of Science][Medline]<\/p>\n

Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature ( 2000;) 407:: 249\u201357. [CrossRef][Medline]<\/p>\n

Patel NG, Haydak MH, Gochnauer TA. Electrophoretic components of the proteins in honeybee larval food. Nature ( 1960;) 186:: 633\u20134. [CrossRef][Web of Science][Medline]<\/p>\n

Shinoda M, Nakajin S, Oikawa T, Sato K, Kamogawa A, Akiyama Y. Biochemical studies on vasodilative factor in royal jelly [in Japanese]. Yakugaku Zasshi ( 1978;) 98:: 139\u201345. [Web of Science][Medline]<\/p>\n

Kawamura J. Influence of gelee royale on embryos [in Japanese]. J Showa Med Assoc ( 1961;) 20:: 1465\u201371.<\/p>\n

Yatsunami K. Echigo T. Antibacterial action of royal jelly. Bull Fac Agr Tamagawa Univ ( 1985;) 25:: 13\u201322.<\/p>\n

Tamura T, Fujii A, Kuboyama N. Antitumor effect of royal jelly [in Japanese]. Folia Pharmacol Japon ( 1987;) 89:: 73\u201380. [CrossRef]<\/p>\n

Townsend GF, Morgan JF, Hazlett B. Activity of 10-hydroxydecenoic acid from royal jelly against experimental leukemia and ascetic tumors. Nature ( 1959;) 183:: 1270\u20131. [CrossRef][Medline]<\/p>\n

Townsend GF, Morgan JF, Tolnai S, Hazlett B, Morton HJ, Shuel RW. Studies on the in vitro antitumor activity of fatty acids I. 10-hydroxy-2-decenoic acid from royal jelly. Cancer Res ( 1960;) 20:: 503\u201310. [Abstract\/Free Full Text]<\/p>\n

Nakajin S, Okiyama K, Yamashita S, Akiyama Y, Shinoda M. Effect of royal jelly on experimental hypercholesterolemia in rabbits [in Japanese]. Yakugaku Zasshi ( 1982;) 36:: 65\u20139.<\/p>\n

Fujii A, Kobayashi S, Kuboyama N, Furukawa Y, Kaneko Y, Ishihama S, et al. Augmentation of wound healing by royal jelly (RJ) in streptozotocin-diabetic rats. Jp J Pharmacol ( 1990;) 53:: 331\u20137. [CrossRef]<\/p>\n

Takenaka T. Chemical composition of royal jelly. Honeybee Sci ( 1982;) 3:: 69\u201374.<\/p>\n

Echigo T, Takenaka T, Yatsunami K. Comparative studies on chemical composition of honey, royal jelly and pollen loads. Bull Fac Agr Tamagawa Univ ( 1986;) 26:: 1\u201312.<\/p>\n

Townsend GF, Brown WH, Felauer EE, Hazlett B. Studies on the in vitro antitumor activity of fatty acids. The esters of acids closely related to 10-hydroxy-2-decenoic acid from royal jelly against transplantable mouse leukemia. Can J Biochem Physiol ( 1961;) 39:: 1765\u201370. [Medline]<\/p>\n

Maeda T, Kuroda H, Motoyoshi K. Effects of royal jelly and 10-hydroxy decenoic acid on the sebaceous glands of hamster ear. Jpn J Dermatol ( 1987;) 98:: 469\u201375.<\/p>\n

Koya-Miyata S, Okamoto I, Ushio S, Iwaki K, Ikeda M, Kuramoto M. Identification of a collagen production-promoting factor from an extract of royal jelly and its possible mechanism. Biosci Biotechnol Biochem ( 2004;) 68:: 767\u201373. [CrossRef][Medline]<\/p>\n

Blum MS, Novak AF, Taber S III. 10-Hydroxy-2-decenoic acid, an antibiotic found in royal jelly. Science ( 1959;) 130:: 452\u20133. [Abstract\/Free Full Text]<\/p>\n

Daniela P, Silvia P, Valentina U, GianLuigi C, Paola M. Pro-collagen I COOH-terminal trimer induces directional migration and metalloproteinases in breast cancer cells. J Biochem ( 2003;) 278:: 3639\u201347.<\/p>\n

Martin MU, Ruth M, Ingrid F, Tatyana S, Jaroslav C, Roman AB, et al. Valproic acid inhibits angiogenesis in vitro and in vivo. J Nutr ( 2004;) 134:: 299\u2013307. [Abstract\/Free Full Text]<\/p>\n

Samid D, Shack S, Sherman LT. Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res ( 1992;) 52:: 1988\u201392. [Abstract\/Free Full Text]<\/p>\n

Patricia AM, Danilo Z, Clemet I, Mary MV, Suzanne FS, Sibel OM, et al. Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. J Nutr ( 2004;) 134:: 299\u2013307. [Abstract\/Free Full Text]<\/p>\n

Wright TJ, Leach L, Shaw PE, Jones P. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells. Exp Cell Res ( 2002;) 280:: 159\u201368. [CrossRef][Web of Science][Medline]<\/p>\n

Lin MT, Yen ML, Lin CY, Kuo ML. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol ( 2003;) 64:: 1029\u201336. [Abstract\/Free Full Text]<\/p>\n

Beecken WD, Engl T, Hofmann J, Jonas D, Blaheta R. Clinical relevance of serum angiogenic activity in patients with transitional cell carcinoma of the bladder. J Cell Mol Med ( 2005;) 9:: 655\u201361. [CrossRef][Web of Science][Medline]<\/p>\n

Oak JH, Nakagawa K, Oikawa S, Miyazawa T. Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells. FEBS Lett ( 2003;) 555:: 419\u201323. [CrossRef][Web of Science][Medline]<\/p>\n

Meghna UN, Ulhas PN. Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin\u00a0 \u03b2 specific. J Cell Sci ( 2005;) 119:: 490\u20139. [CrossRef][Web of Science]<\/p>\n

Tokunaga KH, Yoshida C, Suzuki KM, Maruyama H, Futamura Y, Araki Y, et al. Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats. Biol Pharm Bull ( 2004;) 27:: 189\u201392. [CrossRef][Web of Science][Medline]<\/p>\n

Tamarat R, Silvestre JS, Durie M, Levy BI. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest ( 2002;) 82:: 747\u201356. [Web of Science][Medline]<\/p>\n

Nadal JA, Scicli GM, Carbini LA, Scicli AG. Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB. Am J Physiol Heart Circ Physiol ( 2002;) 282:: 739\u201348.<\/p>\n

Propolis ile ilgili baz\u0131 ara\u015ft\u0131rma\/referanslar:<\/p>\n

Bankova VS, Castro SL, Marcucci MC. Propolis: recent advances in chemistry and plant origin. Apidologie ( 2000;) 31:: 3\u201315. [CrossRef]<\/p>\n

Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytother Res ( 2001;) 15:: 561\u201371. [CrossRef][Web of Science][Medline]<\/p>\n

Huang MT, Ma W, Yen P, Xie JG, Han J, Frenkel K, et al. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells. Carcinogenesis ( 1996;) 17:: 761\u20135. [Abstract\/Free Full Text]<\/p>\n

Sforcin JM, Kaneno R, Funari SRC. Absence of seasonal effect on the immunomodulatory action of Brazilian propolis on natural killer activity. J Venom Anim Toxins ( 2002;) 8:: 19\u201329.<\/p>\n

Scheller S, Gazda G, Pietsz G, Gabrys J, Szumlas J, Eckert L, et al. The ability of ethanol extract of propolis to stimulate plaque formation in immunized mouse spleen cells. Pharmacol Res Commun ( 1988;) 20:: 323\u20138. [Web of Science][Medline]<\/p>\n

Bazo AP, Rodrigues MAM, Sforcin JM, Camargo JLV, Ribeiro LR, Salvadori DMF. Protective action of propolis on the rat colon carcinogenesis. Teratog Carcinog Mutagen ( 2002;) 22:: 183\u201394. [CrossRef][Web of Science][Medline]<\/p>\n

Alves De Lima RO, Bazo AP, Said RA, Sforcin JM, Bankova V, Darros BR, et al. Modifying effect of propolis on dimethylhydrazine-induced DNA damage but not colonic aberrant crypt foci in rats. Environ Mol Mutagen ( 2005;) 45:: 8\u201316. [CrossRef][Web of Science][Medline]<\/p>\n

Bassani-Silva S, Sforcin JM, Amaral AS, Gaspar LFJ, Rocha NS. Propolis effect in vitro on venereal transmissible canine tumor. Rev Port Ci\u00eanc Vet .in press.<\/p>\n

Lima ME, Rissino JD, Guimar\u00e3es AC, Overal DJ, Khayat AS, Souza PC, et al. Drifter technique: a new method to obtain metaphases in HEp-2 cell line cultures. Braz Arch Biol Technol ( 2005;) 48:: 537\u201340.<\/p>\n

Orsi RO, Sforcin JM, Funari SRC, Bankova V. Effects of Brazilian and Bulgarian propolis on bactericidal activity of macrophages against Salmonella typhimurium. Int Immunopharmacol ( 2005;) 5:: 359\u201368. [CrossRef][Web of Science][Medline]<\/p>\n

Boudourova-Krasteva G, Bankova V, Sforcin JM, Nikolova N, Popov S. Phenolics from Brazilian propolis. Z Naturforsch ( 1997;) 52c:: 676\u20139.<\/p>\n

Bankova V, Boudourova\u2013Krasteva G, Popov S, Sforcin JM, Funari SRC. Seasonal variations in essential oil from Brazilian propolis. J Essent Oil Res ( 1998a;) 10:: 693\u20136.<\/p>\n

Bankova V, Boudourova\u2013Krasteva G, Popov S, Sforcin JM, Funari SRC. Seasonal variations of the chemical composition of Brazilian propolis. Apidologie ( 1998b;) 29:: 361\u20137. [CrossRef]<\/p>\n

ZarR JH. Biostatistical Analysis ( 1996;) 2nd. Englewood Cliffs: Prentice-Hall. 718.<\/p>\n

Bankova V, Boudourova-Krasteva G, Sforcin JM, Frete X, Kujumgiev A, Maimoni-Rodella R, et al. Phytochemical evidence for the plant origin of Brazilian propolis from S\u00e3o Paulo state. Z Naturforsch ( 1999;) 54c:: 401\u20135.<\/p>\n

Bankova V. Recent trends and important developments in propolis research. Evid Based Complement Alternat Med ( 2005;) 2:: 29\u201332. [Abstract\/Free Full Text]<\/p>\n

Jin UH, Chung TW, Kang SK, Suh SJ, Kim JK, Chung KH, et al. Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification. Clin Chim Acta ( 2005;) 362:: 57\u201364. [CrossRef][Web of Science][Medline]<\/p>\n

Lee YJ, Kuo HC, Chu CY, Wang CJ, Lin WC, Tseng TH. Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem Pharmacol ( 2003;) 66:: 2281\u20139. [CrossRef][Web of Science][Medline]<\/p>\n

Aso K, Kanno S, Tadano T, Satoh S, Ishikawa M. Inhibitory effect of propolis of the growth of human leukemia U937. Biol Pharm Bull ( 2004;) 27:: 727\u201330. [CrossRef][Web of Science][Medline]<\/p>\n

Kuo HC, Kuo WH, Lee YJ, Lin WL, Chou FP, Tseng TH. Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo. Cancer Lett ( 2006;) 234:: 199\u2013208. [CrossRef][Web of Science][Medline]<\/p>\n

Lee YT, Don MJ, Hung PS, Shen YC, Lo YS, Chang KW, et al. Cytotoxicity of phenolic acid phenethyl esters on oral cancer cells. Cancer Lett ( 2005;) 223:: 19\u201325. [CrossRef][Web of Science][Medline]<\/p>\n

Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, et al. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agr Food Chem ( 2003;) 51:: 7907\u201312. [CrossRef]<\/p>\n

Orsolic N, Saranovic AB, Basic I. Direct and indirect mechanism(s) of antitumour activity of propolis and its polyphenolic compounds. Planta Med ( 2006;) 72:: 20\u20137. [CrossRef][Web of Science][Medline]<\/p>\n

Shimizu K, Das SK, Hashimoto T, Sowa Y, Yoshida T, Sakai T, et al. Artepillin C in Brazilian propolis induces G(0)\/G(1) arrest via stimulation of Cip1\/p21 expression in human colon cancer cells. Mol Carcinog ( 2005;) 44:: 293\u20139. [CrossRef][Web of Science][Medline]<\/p>\n

Kimoto T, Aga M, Hino K, Koya-Miyata S, Yamamoto Y, Micallef MJ, et al. Apoptosis of human leukemia cells induced by Artepillin C, an active ingredient of Brazilian propolis. Anticancer Res ( 2001;) 21:: 221\u20138. [Web of Science][Medline]<\/p>\n

Inokuchi Y, Shimazawa M, Nakajima Y, Suemori S, Mishima S, Hara H. Brazilian green propolis protects against retinal damage in vitro and in vivo. Evid Based Complement Alternat Med ( 2006;) 3:: 71\u20137. [Abstract\/Free Full Text]<\/p>\n

Trusheva B, Popova M, Bankova V, Simova S, Marcucci MC, Miorin PL, et al. Bioactive constituents of Brazilian red propolis. Evid Based Complement Alternat Med ( 2006;) 3:: 249\u201354. [Abstract\/Free Full Text]<\/p>\n

Missima F, Sforcin JM. Green Brazilian propolis action on macrophages and lymphoid organs of chronically stressed mice. Evid Based Complement Alternat Med .in press.<\/p>\n

Sforcin JM. Propolis and the immune system: a review. J Ethnopharmacol ( 2007;) 113:: 1\u201314. [CrossRef][Web of Science][Medline]<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

<\/div><\/div><\/div><\/section><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":2209,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=\/wp\/v2\/pages\/2233"}],"collection":[{"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2233"}],"version-history":[{"count":2,"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=\/wp\/v2\/pages\/2233\/revisions"}],"predecessor-version":[{"id":2235,"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=\/wp\/v2\/pages\/2233\/revisions\/2235"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=\/wp\/v2\/media\/2209"}],"wp:attachment":[{"href":"https:\/\/www.powerterapi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}